A Randomized, Open-label, Phase 3 Trial of A+AVD Versus

Project: Research project

Project Details

Description

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
StatusActive
Effective start/end date12/1/123/28/30

Funding

  • MILLENNIUM PHARMACEUTICALS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.